SCHEMBL24713080

SCHEMBL24713080

C=NC(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(Cc2ccccc2)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SSTR2 P30874 7/20 0.51
▸ SSTR4 P31391 7/20 0.51
▸ SSTR3 P32745 7/20 0.51
▸ SSTR5 P35346 6/20 0.51
▸ SSTR1 P30872 5/20 0.51
▸ CTSG P08311 2/20 0.50
▸ PLAU P00749 2/20 0.48
▸ CACNA1B Q00975 1/20 0.44
▸ TNFSF11 O14788 1/20 0.44
▸ ITGB3 P05106 1/20 0.44
▸ ITGB1 P05556 1/20 0.44
▸ ITGAV P06756 1/20 0.44
▸ ITGA5 P08648 1/20 0.44
▸ ITGB5 P18084 1/20 0.44
▸ KLKB1 P03952 2/20 0.43
▸ KDM4A O75164 1/20 0.43
▸ PRKACA P17612 1/20 0.43
▸ PRKACG P22612 1/20 0.43
▸ PRKACB P22694 1/20 0.43
▸ PIN1 Q13526 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24713050 0.94 SSTR2 (0.53) SSTR2SSTR4SSTR3SSTR5SSTR1
SCHEMBL19806987 0.85 PIN1 (0.51) SSTR2SSTR4SSTR3SSTR5SSTR1
SCHEMBL24713036 0.85 TSLP (0.51) SSTR2SSTR4SSTR3SSTR5SSTR1
SCHEMBL19807066 0.83 PIN1 (0.49) SSTR2SSTR4SSTR3SSTR5SSTR1
SCHEMBL19807007 0.75 CTSG (0.50) SSTR2SSTR4SSTR3SSTR5SSTR1
SCHEMBL29388680 0.74 PLAU (0.59) CTSGPLAUCACNA1BITGB3ITGB1
SCHEMBL24713350 0.73 PIN1 (0.53) CTSGPLAUCACNA1BITGB3ITGB1
SCHEMBL12146083 0.73 TSLP (0.56) CTSGPLAU
SCHEMBL13319649 0.73 CTSG (0.69) CTSGPLAUKLKB1
SCHEMBL19806911 0.73 KEAP1 (0.47) SSTR2SSTR4SSTR3SSTR5SSTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220387608-A1 ADRENOMEDULLIN-ANALOGUES FOR LONG-TERM STABILIZATION AND THEIR USE BAYER AKTIENGESELLSCHAFT (DE) 2022-12-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220387608-A1 ADRENOMEDULLIN-ANALOGUES FOR LONG-TERM STABILIZATION AND THEIR USE VEGFA, ADM2, SERPINA6 SSTR2 692/4885SSTR4 516/4885SSTR3 654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback